Serum globulin in children with myasthenia gravis: predicting relapse and prognosis

References

• O’Connell K, Ramdas S, Palace J. Management of juvenile myasthenia gravis. Front Neurol. 2020;11:743. doi: 10.3389/fneur.2020.00743
   PubMed Web of Science ®Google Scholar
• Mansukhani SA, Bothun ED, Diehl NN, et al. Incidence and ocular features of pediatric myasthenias. Am J Ophthalmol. 2019;200:242–249. doi: 10.1016/j.ajo.2019.01.004
   PubMed Web of Science ®Google Scholar
• He D, Zhang H, Xiao J, et al. Molecular and clinical relationship between live-attenuated Japanese encephalitis vaccination and childhood onset myasthenia gravis. Ann Neurol. 2018;84(3):386–400. doi: 10.1002/ana.25267
   PubMed Web of Science ®Google Scholar
• Weng YY, Yang DH, Qian MZ, et al. Low serum albumin concentrations are associated with disease severity in patients with myasthenia gravis. Medicine. 2016;95(39):e5000. doi: 10.1097/MD.0000000000005000
   PubMed Web of Science ®Google Scholar
• Huda R. Inflammation and autoimmune myasthenia gravis.Front Immunol. Front Immunol. 2023;14:1110499. doi: 10.3389/fimmu.2023.1110499
   PubMed Web of Science ®Google Scholar
• Du XJ, Tang LL, Mao YP, et al. The pretreat-ment albumin to globulin ratio has predictive value for long-term mortality in nasopharyngeal carcinoma. PLOS ONE. 2014;9(4):e94473.
   PubMed Web of Science ®Google Scholar
• Liu MC, Wang LW. Prognostic significance of preoperative serum albumin, albumin-to-globulin ratio and prognostic nutritional index for patients with glioma: a meta-analysis. Medicine. 2020;99(27):e20927. doi: 10.1097/MD.0000000000020927
   PubMed Web of Science ®Google Scholar
• Yang DH, Su ZQ, Wu SJ, et al. Low antioxidant status of serum bilirubin, uric acid, albumin and creatinine in patient with myasthenia gravis. Int J Neurosci. 2016;126(12):1120–1126.
   PubMed Web of Science ®Google Scholar
• Zhang WJ, Zhangyuan GY, Wang F, et al. High preoperative serum globulin in hepatocellular carcinoma is a risk factor for poorsurvival. J Cancer. 2019;10(15):3494–3500. doi: 10.7150/jca.29499
   PubMed Web of Science ®Google Scholar
• Wang LL, Zhang Y, He ML. Clinical predictors for the prognosis of myasthenia gravis. BMC neurol. 2017;17(1):77. doi: 10.1186/s12883-017-0857-7
   PubMedGoogle Scholar
• Jaretzki A, Barohn RJ, Ernstoff RM, et al. Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Ann Thorac Surg. 2000;70(1):327–334. doi: 10.1016/s0003-4975(00)01595-2
   PubMed Web of Science ®Google Scholar
• Vilquin JT, Bayer AC, Le Panse R, et al. The muscle is not a passive target in myasthenia gravis. Front Neurol. 2019;10:1343. doi: 10.3389/fneur.2019.01343
   PubMed Web of Science ®Google Scholar
• Wang LL, Wang SM, Yang HN, et al. No correlation between acetylcholine receptor antibody concentration and individual clinical symptoms of myasthenia gravis: a systematic retrospective study involving 67 p-atients. Brain Behav. 2021;11(7):e02203.
   PubMed Web of Science ®Google Scholar
• Chou CC, Su IC, Chou IJ, et al. Correlation of anti-acetylcholine Receptor antibody levels and long-term outcomes of juvenile myasthenia gravis in Taiwan: a case control study. BMC neurol. 2019;19(1):170. doi: 10.1186/s12883-019-1397-0
   PubMedGoogle Scholar
• Du XJ, Tang LL, Mao YP, et al. The pretreatment albumin to globulin ratio has predictive value for long-term mortality in nasopharyngeal carcinoma. PLOS ONE. 2014;9(4):e94473.
   PubMed Web of Science ®Google Scholar
• Cupp MA, Cariolou M, Tzoulaki I, et al. Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies. BMC Med. 2020;18(1):360. doi: 10.1186/s12916-020-01817-1
   PubMed Web of Science ®Google Scholar
• Xin YZ, Cai HF, Wu LH, et al. The effect of immunonutrition on the posto-perative complications in thymoma with myasthenia gravis. Mediators Inflamm. 2016;2016:8781740. doi: 10.1155/2016/8781740
   PubMed Web of Science ®Google Scholar
• Molin CJ, Westerberh E, Punga AR. Profile of upregulated inflammatory proteins in sera of myasthenia gravis patients. Scic Rep. 2017;7(1):39716. doi: 10.1038/srep39716
   PubMedGoogle Scholar
• Barbo-Sasilva MCG. Subjective and objective nutritional assessment methods: what do they really assess? Curr Opin Clin Nutr Metab Care. 2008;11(3):248–254. doi: 10.1097/MCO.0b013e3282fba5d7
   PubMed Web of Science ®Google Scholar
• Green MD. Acute phase responses to novel, investigational vaccines in toxicology studies: the relationship between C-reactive protein and other acute phase proteins. Int J Toxicol. 2015;34(5):379–383. doi: 10.1177/1091581815598750
   PubMed Web of Science ®Google Scholar
• Bi ZJ, Cao YY, Liu CC, et al. Remission and relapse of myasthenia gravis on long-term tacrolimus: a retrospective cross-sectional study of a Chinese cohort. Ther Adv Chronic Dis. 2022;13:20406223221122538. doi: 10.1177/20406223221122538
   Web of Science ®Google Scholar
• Popperud TH, Boldingh MI, Rasmussen M, et al. Juvenile myasthenia gravis in Norway: clinical characteristics, treatment, and long-term outcome in a nation-wide population-based cohort. Eur J Paediatr Neurol. 2017;21(5):707–714. doi: 10.1016/j.ejpn.2017.04.003
   PubMed Web of Science ®Google Scholar
• Lee HN, Kang HC, Lee JS, et al. Juvenile myasthenia gravis in Korea: Subgroup analysis according to sex and onset age. J Child Neurol. 2016;31(14):1561–1568. doi: 10.1177/0883073816666206
   PubMed Web of Science ®Google Scholar
• Su SY, Lei L, Fan ZR, et al. Clinical predictors of relapse in a cohort of steroid-treated patients with well-controlled myasthenia gravis. Front Neurol. 2022;13:816243. doi: 10.3389/fneur.2022.816243
   PubMed Web of Science ®Google Scholar
• Vecchio D, Ramdas S, Munot P, et al. Paediatric myasthenia gravis: prognostic factors for drug free remission. Neuromuscular Disorders. 2020;30(2):120–127. doi: 10.1016/jnmd.2019.11.008
   PubMed Web of Science ®Google Scholar
• Yoshimoto Y, Ishida S, Hosokawa T, et al. Assessment of clinical factors affecting outcme of myasthenia gravis. Muscle Nerve. 2021;64(1):90–94. doi: 10.1002/mus.27247
   PubMed Web of Science ®Google Scholar